Clinical Trial Update: Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors

View source ↗

Summary

Real-life observational update on Caduet (amlodipine/atorvastatin) in patients with cardiovascular risk factors; study terminated with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Risk Factors
• Hypertension

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension and Cardiovascular Risk Factors | Status: TERMINATED | Results posted: 2009-06-19